DK1196170T3 - Anvendelse af en makrolidforbindelse til fremstilling af et medikament til behandling af hjerneskade forårsaget af iskæmi eller blödning - Google Patents

Anvendelse af en makrolidforbindelse til fremstilling af et medikament til behandling af hjerneskade forårsaget af iskæmi eller blödning

Info

Publication number
DK1196170T3
DK1196170T3 DK00946165T DK00946165T DK1196170T3 DK 1196170 T3 DK1196170 T3 DK 1196170T3 DK 00946165 T DK00946165 T DK 00946165T DK 00946165 T DK00946165 T DK 00946165T DK 1196170 T3 DK1196170 T3 DK 1196170T3
Authority
DK
Denmark
Prior art keywords
ischemia
bleeding
medicament
manufacture
treatment
Prior art date
Application number
DK00946165T
Other languages
Danish (da)
English (en)
Inventor
Paul Alexander Jones
John Sharkey
John Shearer Kelly
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK1196170T3 publication Critical patent/DK1196170T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DK00946165T 1999-07-21 2000-07-19 Anvendelse af en makrolidforbindelse til fremstilling af et medikament til behandling af hjerneskade forårsaget af iskæmi eller blödning DK1196170T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9917158.9A GB9917158D0 (en) 1999-07-21 1999-07-21 New use

Publications (1)

Publication Number Publication Date
DK1196170T3 true DK1196170T3 (da) 2004-08-30

Family

ID=10857695

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00946165T DK1196170T3 (da) 1999-07-21 2000-07-19 Anvendelse af en makrolidforbindelse til fremstilling af et medikament til behandling af hjerneskade forårsaget af iskæmi eller blödning

Country Status (15)

Country Link
US (1) US20060287353A1 (fr)
EP (1) EP1196170B1 (fr)
JP (1) JP2003504396A (fr)
KR (1) KR100508623B1 (fr)
CN (1) CN1200710C (fr)
AT (1) ATE270888T1 (fr)
AU (1) AU6003900A (fr)
CA (1) CA2379140A1 (fr)
DE (1) DE60012183T2 (fr)
DK (1) DK1196170T3 (fr)
ES (1) ES2220492T3 (fr)
GB (1) GB9917158D0 (fr)
HK (1) HK1047704B (fr)
PT (1) PT1196170E (fr)
WO (1) WO2001005385A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035411A1 (es) * 2000-12-29 2004-05-26 Fujisawa Pharmaceutical Co Uso de un derivado de tacrolimus para fabricar un agente neurotrofico, composiciones y articulos de fabricacion o kits que lo comprenden, metodo para fabricar un agente que lo comprende y tejidos e injertos con una celula nerviosa tratada con este compuesto
AU2003901023A0 (en) * 2003-03-04 2003-03-20 Fujisawa Pharmaceutical Co., Ltd. New use
MXPA06008180A (es) * 2004-01-20 2006-08-31 Astellas Pharma Inc Metodo para tratar disfuncion erectil.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
GB8728820D0 (en) * 1987-12-09 1988-01-27 Fisons Plc Compounds
GR1001225B (el) * 1989-09-14 1993-06-30 Fisons Plc Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους.
GB9202196D0 (en) * 1992-02-01 1992-03-18 Fisons Plc Method of treatment
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
GB9227055D0 (en) * 1992-12-29 1993-02-24 Fujisawa Pharmaceutical Co New use

Also Published As

Publication number Publication date
WO2001005385A3 (fr) 2001-08-02
KR100508623B1 (ko) 2005-08-17
CN1361691A (zh) 2002-07-31
KR20020060148A (ko) 2002-07-16
ATE270888T1 (de) 2004-07-15
CA2379140A1 (fr) 2001-01-25
JP2003504396A (ja) 2003-02-04
WO2001005385A2 (fr) 2001-01-25
US20060287353A1 (en) 2006-12-21
PT1196170E (pt) 2004-10-29
ES2220492T3 (es) 2004-12-16
DE60012183D1 (de) 2004-08-19
EP1196170B1 (fr) 2004-07-14
DE60012183T2 (de) 2004-11-18
AU6003900A (en) 2001-02-05
GB9917158D0 (en) 1999-09-22
HK1047704A1 (en) 2003-03-07
HK1047704B (zh) 2005-12-16
EP1196170A2 (fr) 2002-04-17
CN1200710C (zh) 2005-05-11

Similar Documents

Publication Publication Date Title
ATE344226T1 (de) Aspirin-ausgelöste lipidmediatoren
NL300933I2 (nl) Letermovir
CR8273A (es) Administracion de ligandos de tlr7 y profarmacos de los mismos para el tratamiento de la infeccion por el virus de hepetitis c
CY1121284T1 (el) Θεραπεια ασθενειων που συνδυαζονται με τη χρηση αντιβιοτικων
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
WO2002080890A3 (fr) Composition pharmaceutique de jasmonate pour le traitement du cancer
ID29107A (id) Metoda pengobatan iskemia serebral dan penggunaannya eritropoetin atau turunan eritropoetin untuk penggunaan iskemia serebral
DK1066056T3 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, ...
NO20061184L (no) Fremgangsmater og blandinger for behandling av herpes-infeksjoner
TNSN04100A1 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof , the use thereof as medicaments, in addition to a medicament containing same
NO983991L (no) Serin-protease-inhibitorer
PT1300084E (pt) Composicaio para o tratamento de insuficiencias venosas cronicas melha.
DK1150704T3 (da) Melagatran til behandling af betændelse
DK1196170T3 (da) Anvendelse af en makrolidforbindelse til fremstilling af et medikament til behandling af hjerneskade forårsaget af iskæmi eller blödning
BRPI0512732A (pt) formulações tópicas para tratamento de doenças alérgicas
PA8531601A1 (es) Nuevos heteroaromatos
SE0200198D0 (sv) New use
WO2004078115A3 (fr) Composes de benzothiazole, compositions et procedes pour le traitement et la prophylaxie des infections par rotavirus et des maladies associees
NO20021710L (no) Anvendelse av 2-amino-3,4-dihydro-kinazoliner for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander
DK1343523T3 (da) Anvendelse af aktiveret faktor VII til behandling af thrombolytisk terapi-inducerede alvorlige blödninger
BR0007395B1 (pt) compostos de s-nitrosotióis como agentes para o tratamento de disfunções circulatórias.
WO2021107656A3 (fr) Nouveau dérivé d'oxydo-réduction de la quercétine et son utilisation en tant qu'inhibiteur de bet
NO20021909D0 (no) Anvendelse av 2-imidazolylsubstituerte karbinoler for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander
BR0107442A (pt) Utilização da enoxaparina
WO2002057286A3 (fr) Derives de 9-amino erythromycine a activite antibacterienne